It takes up to 15 years and an average total R&D expenditure of $1.5–2 billion USD to bring a single new drug to market. About half of this investment is spent on clinical trials, with Phase III trials being the most complex and most expensive. Probabilities of success for compounds…

Over the past few weeks we have been meeting internally to define our strategy and goals in the runup to the new year. To this end we published the outline of our 2023 updated roadmap on the ClinTex homepage. Allow us a moment to briefly dive a little deeper into…

Clintex are excited to announce the signing of an agreement with LVL Health (https://lvlhealth.co.uk/) to support their CANPAIN clinical trial (https://clinicaltrials.gov/ct2/show/NCT05288010) evaluating Cannabis Based Medicinal Products (CBMPs) in the treatment of Chronic Pain. This clinical trial is particularly high profile as it is being conducted to provide key data to…

The autumnal months have begun to set in here in Europe as the crypto bear market drags on, mirroring the wider global macro economic uncertainty that has been so evident thus far in 2022. To say it has been a tumultuous year so far would be an understatement, however here…

We are extremely excited to announce that ClinTex are currently in active discussions with two ground breaking companies, to support clinical trials in the application of medicinal cannabis to manage chronic pain. Celadon Pharmaceuticals recently released a substantial business update since announcing to become the first British cannabis company since…

Since 2018, when the UK Home Office announced that cannabis-based medicinal products (CBMPs) were to be moved from Schedule 1 to Schedule 2 status in the misuse of drugs regulations, ClinTex have been closely monitoring associated clinical trials which can help prove that these compounds possess untapped medical utility. One…

A big hello to one and all out there in blockchain land, from ClinTex HQ! It’s been a busy year so far, as we approach the halfway point in 2022 already. Although it’s fair to say that this could possibly be referred in many ways to an annus horribilis for…

The date has finally arrived! We are delighted to announce that $CTI token has been officially upgraded to a sleeker, more efficient, more decentralized and cross-chain compatible iteration — $CTI2.0 The official new CTI2.0 Ethereum Contract ID is : 0xcB8fb2438A805664cD8c3e640b85AC473DA5BE87 https://etherscan.io/token/0xcb8fb2438a805664cd8c3e640b85ac473da5be87 The official new CTI2.0 on Solana Contract ID is…

As you may well be aware, it’s been a while in the works, but we’re delighted to announce that we’re finally there, CTI2.0 is ready for action! After many weeks and in the end, months of designing, building, testing and re-building, we are now confident that we have the contract…